ARTICLE | Clinical News
AP24534 regulatory update
January 4, 2010 8:00 AM UTC
EMEA's Committee for Orphan Medicinal Products (COMP) granted Orphan Drug designation to Ariad's AP24534 to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). The oral B...